Current practice patterns of primary care physicians in the management of patients with hepatitis C

Hepatology

Volumn 30, Issue 3, 1999, Pages 794-800

  Shehab, Thomas M ^a   Sonnad, Seema S ^a   Jeffries, Mark ^a,b   Gunaratnum, Naresh ^a,c   Lok, Anna S F ^a,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CLINICAL PRACTICE; DISEASE TRANSMISSION; EDUCATION PROGRAM; GENERAL PRACTICE; HEPATITIS C; HUMAN; INFECTION RISK; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR;

BLOOD TRANSFUSION; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 0032819161     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300328     Document Type: Article

References (18)

1. Alter MJ. Epidemiology of hepatitis C. HEPATOLOGY 1997;26(Suppl 1):62S-65S.
2. Powell DW for the Hepatitis C Consensus Development Panel. National Institutes of Health consensus development conference panel statement: management of hepatitis C. HEPATOLOGY 1997;26(Suppl 1):2S-10S.
3. Fendrick AM, Hirth RA, Chernew ME. Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease. Am J Gastroenterol 1996;91:1544-1548.
4. Everhart JE, Stolar M, Hoofnagle JH. Management of hepatitis C: a national survey of gastroenterologists and hepatologists. HEPATOLOGY 1997;26(Suppl 1):78S-82S.
5. Dienstag JL. Sexual and perinatal transmission of hepatitis C. HEPATOLOGY 1997;26(Suppl 1):66S-70S.
6. Alter MJ, Margolis HS. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease, MMWR 1998;47(RR-19):l-54.
7. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion transmitted viral infection. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-1690.
8. Conry-Catilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:1691-1696.
9. Marcellin P, Levy S, Erlinger S. Therapy of hepatitis C: patients with normal aminotransferase levels. HEPATOLOGY 1997;26(Suppl l):133S-136S.
10. Carithers RL, Emerson SS. Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials. HEPATOLOGY 1997;26(Suppl 1):83S-88S.
11. Lee WM. Therapy of hepatitis C: interferon alfa-2a trials. HEPATOLOGY 1997;26(Suppl 1):88S-95S.
12. Lindsay KL. Therapy of hepatitis C: overview. HEPATOLOGY 1997; 26(Suppl 1):71S-77S.
13. Gretch DR. Diagnostic tests for hepatitis C. HEPATOLOGY 1997;26(Suppl D.-43S-47S.
14. Lok ASF, Gunaratnum NT. Diagnosis of hepatitis C. HEPATOLOGY 1997;26(Suppl 1):48S-56S.
15. Keeffe EB, Hollinger FB, and the Consensus Interferon Study Group. Therapy of hepatitis C: consensus interferon trials. HEPATOLOGY 1997; 26(Suppl 1):101S-107S.
16. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as intial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-1492.
17. Onion CVV, Bartzokas CA. Changing attitudes to infection management in primary care: a controlled trial of active versus passive guideline implementation strategies. Fam Pract 1998:15:99-104.
18. Green LW, Kreuter MW. Health Promotion Planning: An Educational and Environmental Approach, 2nd ed. Toronto: Mayfield Publishing Co., 1991.